ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 637651 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 637651; 2) Community: the network communities that were significantly associated with the response to NSC 637651; 3) Molecule: the relationships between components within communities and NSC 637651; 4) MDR: the compounds that were significantly associated with the NSC 637651.

NSC Compound Enrichment Correlation
NSC 691819 Null 0.0446159312763235 0.1160415
NSC 699148 Null 0.0446159312763235 0.13017049
NSC 716344 Null 0.0446159312763235 0.046958604
NSC 726262 1,1'-{[(bispropane-1,N-diyl)piperzine]dioxy}bis[(11aS)-7-met hoxy-1,2,3,11a-tetrahydro-5H-pyrrolo[2,1-c][1,4]benzodiazepi n-5-one 0.0446159312763235 0.21388761
NSC 740276 5,6-Dihydro-6-[3-(hydroxyethyl)amino-1-propyl]-5,11-dioxo-11H-indeno[1,2-c]isoquinoline Hydrochloide 0.0446159312763235 0.090336071
NSC 127157 Null 0.0459335986102865 0.25215699
NSC 144173 Quinoxaline, 2,3-bis(iodomethyl)-6-methoxy- 0.0459335986102865 -0.15370354
NSC 150446 Berberine iodide 0.0459335986102865 0.4667957
NSC 157995 Benzo[c]phenanthridinium, 2-hydroxy-3,8,9-trimethoxy-5-methyl-, chloride (9CI) (MF1) 0.0459335986102865 0.59780657
NSC 357704 Cyanomorpholinodoxorubicin 0.0459335986102865 0.2685044
Total:63  Current:52    [First] [Prev] [Next] [Last]